Evaluating the impact of efpeglenatide on cardiometabolic and safety outcomes in individuals with diabetes: a systematic review and meta-analysis.
Shurjeel Uddin QaziHuzaifa Ul Haq AnsariZoaib Habib TharwaniZahabia AltafAyesha NomanShamas GhazanfarSangeet KumarHaya Waseem AnsariMuhammad Moiz NasirSana QaziPublished in: Journal of diabetes and metabolic disorders (2024)
The online version contains supplementary material available at 10.1007/s40200-024-01409-3.